Isavuconazole-induced Acute Liver Failure in a Pediatric Patient With Invasive Aspergillosis
Isavuconazole is a new azole approved for adults with invasive aspergillosis and mucormycosis, with a favorable hepatic tolerability reported in Phase III trials. Here, we report on a case of drug-induced liver failure related to isavuconazole in a pediatric patient treated for invasive aspergillosis after bone marrow transplant.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
The Pediatric infectious disease journal - 38(2019), 10 vom: 01. Okt., Seite 1035-1037 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Brivio, Erica [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
60UTO373KE |
|---|
| Anmerkungen: |
Date Completed 29.04.2020 Date Revised 29.04.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1097/INF.0000000000002418 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM301756678 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM301756678 | ||
| 003 | DE-627 | ||
| 005 | 20231225105304.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/INF.0000000000002418 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1005.xml |
| 035 | |a (DE-627)NLM301756678 | ||
| 035 | |a (NLM)31568141 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Brivio, Erica |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Isavuconazole-induced Acute Liver Failure in a Pediatric Patient With Invasive Aspergillosis |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.04.2020 | ||
| 500 | |a Date Revised 29.04.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Isavuconazole is a new azole approved for adults with invasive aspergillosis and mucormycosis, with a favorable hepatic tolerability reported in Phase III trials. Here, we report on a case of drug-induced liver failure related to isavuconazole in a pediatric patient treated for invasive aspergillosis after bone marrow transplant | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antifungal Agents |2 NLM | |
| 650 | 7 | |a Nitriles |2 NLM | |
| 650 | 7 | |a Pyridines |2 NLM | |
| 650 | 7 | |a Triazoles |2 NLM | |
| 650 | 7 | |a isavuconazole |2 NLM | |
| 650 | 7 | |a 60UTO373KE |2 NLM | |
| 700 | 1 | |a Verna, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Migliorino, Guglielmo Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Foresti, Sergio |e verfasserin |4 aut | |
| 700 | 1 | |a Zucchini, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Rovelli, Attilio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Pediatric infectious disease journal |d 1991 |g 38(2019), 10 vom: 01. Okt., Seite 1035-1037 |w (DE-627)NLM012615706 |x 1532-0987 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2019 |g number:10 |g day:01 |g month:10 |g pages:1035-1037 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/INF.0000000000002418 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2019 |e 10 |b 01 |c 10 |h 1035-1037 | ||